SHANGHAI -- Chinese startup NeuroXess on Thursday reported two significant clinical-trial milestones: its flexible ...

Chinese startup NeuroXess on Thursday reported two significant clinical-trial milestones its flexible brain-computer interface BCI device successfu ...

Nicole Grieselhuber, MD, PhD, of The Ohio State University, discusses results from Part D of a dosing study involving patients with previously untreated higher-risk myelodysplastic syndrome (MDS) who ...

Large research symposium highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices.